Behavior therapy can benefit most patients with attention deficit hyperactivity disorder (ADHD), but the vast majority of patients with the condition will still need pharmacotherapy to manage their symptoms and prevent the disorder from interfering with their lives. Yet little progress has been made in identifying effective agents for patients who don't respond to the handful of existing medications.